Search results
Results From The WOW.Com Content Network
From 1988 until 1992 Weizmann was the executive director of the American Benefits Council, a trade association which actively supports the employer-sponsored pension and health systems. Weizmann was also a lawyer and executive with Sun Company (Sunoco) during the 1980s and spent several years as an attorney in private practice..
This page was last edited on 8 February 2023, at 17:58 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The front door of the administrative building with the former name Koffler particle accelerator. The Weizmann Institute of Science (Hebrew: מכון ויצמן למדע Machon Weizmann LeMada) is a public research university in Rehovot, Israel, established in 1934, fourteen years before the State of Israel was founded.
Yitzhak Maron (Hebrew: יצחק מרון) is a plasma physicist and a professor at the Weizmann Institute of Science. [1] [2] He is known for pioneering spectroscopic techniques to measure and characterize plasmas under extreme conditions (e.g. high-current, high-voltage, high-fields, short-duration) which won him the 2007 IEEE Plasma Science and Applications (PSAC) Award [3] and the 2009 John ...
Eran Elinav (born 22 June 1969 in Jerusalem, Israel) is an Israeli immunologist [1] and microbiota researcher [2] at the Weizmann Institute of Science [3] and the DKFZ. [4]He is an international scholar at the Howard Hughes Medical Institute (HHMI) and the Bill & Melinda Gates Foundation [5] and a senior fellow of the Canadian Institute for Advance Research ().
The last day for FedEx ground economy is Friday Dec. 13, and Wednesday Dec. 18 is the deadline for U.S. Postal Service ground and first-class mail.
Michal Schwartz (born 1 January 1950) is a professor of neuroimmunology at the Weizmann Institute of Science.She is active in the field of neurodegenerative diseases, particularly utilizing the immune system to help the brain fight terminal neurodegenerative brain diseases, such as Alzheimer's disease and dementia.